Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-α in patients with progressive metastatic renal cell carcinoma
暂无分享,去创建一个
M. Kersten | G. Groenewegen | S. Horenblas | J. Sein | A. Bex | F. Vyth-Dreese | W. Nooijen | M. de Waal | N. Verra | W. van de Kasteele | H. Mallo | R. Jansen | G. D. de Gast | G. De Gast